NASDAQ:CRSP
A company insider recently sold 10,000 shares of CRISPR Therapeutics AG [CRSP]. Should You also Consider to Sale?
Daniel Torres
CRISPR Therapeutics AG’s recent filing unveils that its Chief Financial Officer Prasad Raju unloaded Company’s shares for reported $0.56 million ...
CRSP’s latest rating updates from top analysts.
Jaxson Clark
In a filing, CRISPR Therapeutics AG revealed its Chief Financial Officer Prasad Raju unloaded Company’s shares for reported $0.56 million ...
Examining the Potential Price Growth of CRISPR Therapeutics AG (CRSP)
Daniel Torres
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
Understanding the Risks of Investing in CRISPR Therapeutics AG (CRSP)
Roman Campbell
CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
